These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35868414)

  • 1. Association of OPG and RANKL gene polymorphisms with bone mineral density in Indian women.
    Nair S; Bhadricha H; Patil A; Surve S; Joshi B; Balasinor N; Desai M
    Gene; 2022 Oct; 840():146746. PubMed ID: 35868414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".
    Piedra M; García-Unzueta MT; Berja A; Paule B; Lavín BA; Valero C; Riancho JA; Amado JA
    BMC Med Genet; 2011 Dec; 12():168. PubMed ID: 22185226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
    Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
    Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
    Shang M; Lin L; Cui H
    Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.
    Roshandel D; Holliday KL; Pye SR; Boonen S; Borghs H; Vanderschueren D; Huhtaniemi IT; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; O'Neill TW;
    J Bone Miner Res; 2010 Aug; 25(8):1830-8. PubMed ID: 20205168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
    Pereira RMR; Figueiredo CP; Cha CC; Caparbo VF; Oliveira RM; Franco AS; Menezes PR; de Castro I; Onuchic LF
    Osteoporos Int; 2016 Nov; 27(11):3319-3329. PubMed ID: 27311721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of
    Abdi S; Binbaz RA; Mohammed AK; Ansari MGA; Wani K; Amer OE; Alnaami AM; Aljohani N; Al-Daghri NM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
    Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
    Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis.
    Xu S; Ma XX; Hu LW; Peng LP; Pan FM; Xu JH
    Clin Exp Rheumatol; 2014; 32(5):697-704. PubMed ID: 25068378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
    Hayat F; Khan NU; Khan AU; Ahmad I; Alamri AM; Iftikhar B
    PLoS One; 2022; 17(11):e0276813. PubMed ID: 36346787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
    Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men.
    Roshandel D; Holliday KL; Pye SR; Ward KA; Boonen S; Vanderschueren D; Borghs H; Huhtaniemi IT; Adams JE; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; ONeill TW;
    Calcif Tissue Int; 2011 Dec; 89(6):446-55. PubMed ID: 21964949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.
    Tu P; Duan P; Zhang RS; Xu DB; Wang Y; Wu HP; Liu YH; Si L
    Osteoporos Int; 2015 Jan; 26(1):179-85. PubMed ID: 25138264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression.
    Takács I; Lazáry A; Kósa JP; Kiss J; Balla B; Nagy Z; Bácsi K; Speer G; Lakatos P
    Eur J Endocrinol; 2010 Feb; 162(2):423-31. PubMed ID: 19934266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients.
    Wang J; Lu K; Song Y; Zhao S; Ma W; Xuan Q; Tang D; Zhao H; Liu L; Zhang Q
    PLoS One; 2015; 10(7):e0133964. PubMed ID: 26218592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms.
    Eid R; Abdelsalam M; Fathy AA; Abolenein HM; Elmarghany EB; El-Hanafy AA; Hamdy N; Abd-Elmagid DS; Niazy NA; Abd-El Ghaffar DM
    Pediatr Rheumatol Online J; 2023 Jun; 21(1):58. PubMed ID: 37328895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis.
    Yang H; Liu W; Zhou X; Rui H; Zhang H; Liu R
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31209146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VDR, RANKL and OPG polymorphisms as possible predisposing cofactors of postmenopausal osteoporosis: explorative study in Italian population.
    Mamolini E; Cervellati C; Greco P; Carrieri A; Massari L; Crivellari I; Scapoli C; Bonaccorsi G
    Gynecol Endocrinol; 2017 Dec; 33(12):937-941. PubMed ID: 28488893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of the OPG gene associated with breast cancer.
    Ney JT; Juhasz-Boess I; Gruenhage F; Graeber S; Bohle RM; Pfreundschuh M; Solomayer EF; Assmann G
    BMC Cancer; 2013 Jan; 13():40. PubMed ID: 23369128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.